Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
New cancer vaccines research reported from C.M. Travasso and co-authors
July 8th, 2008
Investigators publish new data in the report 'Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India.' According to recent research from India, "Cervical cancer is a leading cause of cancer-related deaths among women in India.Human papillomavirus (HPV) infection is the causative agent of cervical cancer; and infection with the high-risk genotypes, predominantly HPV16 and 18,is the biggest risk factor.Vaccines targeting HPV16 and 18 have been found to confer protection in large-scale clinical trials.HPV genotyping has traditionally been carried out to screen the population 'at risk' using indirect methods based on polymerase chain reaction (PCR)...
Source: Cancer Weekly (2008-07-08)
|
|
Advertisement |
|
|
|
